AVTR NYSE Week ended 24 Jul 2026

Weekly Investor Report

Avantor Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data Download investor PDF
Latest close 11.44 USD
3.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 21.1% above the Trend Line and sits at 48.2% of its 52-week range. The latest completed week returned 3.3%, after a 11.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 62/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: earnings are due in 1d.

Setup score 47 out of 100
Latest Close 11.44 USD 24 Jul 2026
1W Return 3.3% latest completed week
4W Return 11.3% short-term follow-through
12W Return 43.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.3% Latest completed week; four-week move 11.3%. Indicator stack 0/76 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 62/100 conviction; expected move 18.4%. News sentiment 53/100 52 relevant articles in the latest sentiment read. Event risk 1d Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 21.1% above the Trend Line and sits at 48.2% of its 52-week range. The latest completed week returned 3.3%, after a 11.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4312-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.3% over four weeks, 43.7% over 12 weeks, and -19.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.3%
4W11.3%
12W43.7%
26W-3.1%
52W-19.5%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.34Latest activity-pressure read.
Pressure change26.3%Four-week change in activity pressure.
Leadership-1.60Latest relative-leadership reading.
RS change88.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value33/100Relative valuation strength. Underlying universe rank 68; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth23/100Revenue and earnings growth. Underlying universe rank 78; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
89.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
32.1%
Gross profit retained from each unit of revenue.
Operating margin
-4.4%
Operating profit retained from revenue.
Free-cash-flow margin
10.8%
Free cash flow generated from revenue.
Return on invested capital
-2.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-25.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
1.0%
Net share repurchases relative to market value.
Shareholder yield
1.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
27.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

AVTR shows volatility options pressure with a 62/100 conviction score, put-call volume ratio of 0.03, expected move of 18.4%, and Sharemaestro trend signal inactive.

Conviction62/100
Expected move18.4%
Put/call volume0.03
Pressure100
Speculation50
Volatility86
Trend agreement0
Open options detail
Insider activity13 / 1

13 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 52 relevant articles.

22 positive · 19 neutral · 11 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings1dNext report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
Options expected move18.4%Nearest-chain priced movement where available.
52-week drawdown-28.2%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 269 weeks finished lower.
Best week+12.3%Week of 29 May.
Worst week-18.3%Week of 13 Feb.
Latest week+3.3%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains9
Flat weeks1
Modest losses3
Sharp losses6
Recent vol4.7%13-week weekly-return volatility.
Base vol7.6%52-week weekly-return volatility.
Up/down split31/20Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape38/100

Trend, activity pressure, participation, and risk combine to a 38/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.43; No reversal markers Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 31; Small Cap Core rank 71 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options38/100

AVTR shows volatility options pressure with a 62/100 conviction score, put-call volume ratio of 0.03, expected move of 18.4%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 18.4% Sentiment53/100

Weighted news tone is neutral across 52 relevant articles.

NuSil’s Longer-Lasting HIV Prevention Ring Could Be A Game Changer For Avantor (AVTR) Insiders13 / 1

13 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings1d

Next report is scheduled for 31 Jul 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202611.44 USD3.3%9.44 USD17.47 USD1.34-1.6055.5MOff
17 Jul 202611.07 USD6.5%9.44 USD17.53 USD1.22-6.1654.2MOff
10 Jul 202610.39 USD0.7%9.45 USD17.61 USD0.98-13.9637.2MOff
3 Jul 202610.32 USD0.4%9.48 USD17.68 USD1.04-14.2234.2MOff
26 Jun 202610.28 USD7.3%9.50 USD17.74 USD1.06-13.5946.5MOff
19 Jun 20269.58 USD2.0%9.54 USD17.81 USD0.98-22.1329.7MOff
12 Jun 20269.39 USD2.5%9.61 USD17.87 USD0.99-23.8852.2MOff
5 Jun 20269.16 USD0.4%9.68 USD17.94 USD0.60-26.1350.5MOff
29 May 20269.12 USD12.3%9.75 USD18.01 USD0.34-29.0844.9MOff
22 May 20268.12 USD6.6%9.84 USD18.08 USD-0.02-36.6653.6MOff
15 May 20267.62 USD-8.3%10.09 USD18.16 USD-0.45-40.7944.7MOff
8 May 20268.31 USD4.4%10.33 USD18.24 USD-0.59-36.1747.0MOff
1 May 20267.96 USD0.8%10.50 USD18.32 USD-0.90-38.1157.5MOff
24 Apr 20267.90 USD-7.3%10.71 USD18.40 USD-1.13-38.7949.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.